About Polypharm Private Limited
Data last updated:
Polypharm Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 July 1961 and has been in existence for over 65 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1961PTC012054. Its GSTIN is 27AAACP2638N1Z4 (Maharashtra).
The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹19.65 Lakh. It is led by directors including Sudha Prem Gupta and Sheetal Pankaj Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Calcot House 1 Shetty Marg Tamarind Lane, Mumbai, Maharashtra, India – 400001.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.92 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹72.85 Lakh (net margin 8.2%) and EBITDA of ₹1.07 Cr (EBITDA margin 11.9%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 11% over five years.
The company has about 11 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Polypharm. As per MCA filings, the company has open charges of ₹20 Lakh and satisfied charges of ₹31.8 Lakh on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website polypharmindia.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressCalcot House 1 Shetty Marg Tamarind Lane, Mumbai, Maharashtra, India – 400001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Polypharm Private Limited
The main business activity of Polypharm is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Polypharm Private Limited FY 2025 filings available
Polypharm Private Limited reported revenue of ₹8.92 Cr (up 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Polypharm Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 5% growth in the latest year. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Polypharm Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.07 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹72.85 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Polypharm Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 8.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Polypharm are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Polypharm Private Limited
Polypharm Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kudos Laboratories India Limited | ₹8.96 Cr (FY 2023) | •••• | •••• | -30.0% | •••• | Delhi, India |
| Aies Pharma Chem Private Limited | ₹8.95 Cr (FY 2025) | •••• | •••• | 36.0% | •••• | Kalol, Gujarat, India |
| Ish Medicos Private Limited | ₹8.95 Cr (FY 2024) | •••• | •••• | 104.0% | •••• | Dehradun, Uttarakhand, India |
| Genix Lifescience Private Limited | ₹8.94 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | New Delhi, Delhi, India |
| Grapple Lifesciences Private Limited | ₹8.93 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Manimajra, Chandigarh, India |
| Polypharm Private Limited this company | ₹8.92 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Mumbai, Maharashtra, India |
| Sandor Speciality Diagnostics Private Limited | ₹8.91 Cr (FY 2022) | •••• | •••• | 65.0% | •••• | Hyderabad, Telangana, India |
| Derren Healthcare Private Limited | ₹8.91 Cr (FY 2025) | •••• | •••• | 38.0% | •••• | Ahmedabad, Gujarat, India |
| Oviani Pharma Chem Private Limited | ₹8.89 Cr (FY 2024) | •••• | •••• | -22.0% | •••• | Thane, Maharashtra, India |
| Solmed Lifesciences Private Limited | ₹8.89 Cr (FY 2023) | •••• | •••• | -24.0% | •••• | Telangana, India |
| Akin Laboratories Pvt Ltd | ₹8.84 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Polypharm by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Polypharm Private Limited
Polypharm Private Limited is audited by SANJAY RANE & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SANJAY RANE & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Polypharm Private Limited
Polypharm has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudha Prem Gupta Also directs: Gupta Commerce Pvt Ltd | Director | 04 Mar 1997 | 29 Years 7 Months | Current |
| Sheetal Pankaj Gupta Also directs: Gupta Commerce Pvt Ltd | Director | 14 Oct 2021 | 4 Years 11 Months | Current |
| Pankaj Prem Gupta Also directs: Gupta Commerce Pvt Ltd | Director | 04 Mar 1997 | 29 Years 7 Months | Current |
Ownership and Shareholding of Polypharm Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Polypharm Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jan 2011 | Canara Bank | ₹20 Lakh | Open |
| 27 Jul 1988 | State Bank of India | ₹29 Lakh | Satisfied |
| 06 Jun 1981 | State Bank of India | ₹1.4 Lakh | Satisfied |
| 06 Jun 1981 | State Bank of India | ₹1.4 Lakh | Satisfied |
Total charge records: 4 View all charges
Legal Cases of Polypharm Private Limited
Polypharm Private Limited has 3 court cases on record: 2 filed by Polypharm, 1 filed against it. All cases are disposed. Status as checked between 30 Sep 2026 and 01 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Writ petition | Filed by the company against an individual | Disposed |
| Bombay High Court | Court case (CAW) | Filed against the company by an individual | Disposed |
| Bombay High Court | Court case (CAW) | Filed by the company against an individual | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Polypharm Private Limited
Polypharm operates one associated brand: Polypharm. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Supply of pharmaceutical chemicals, solvents, disinfectants, and acids in India. | polypharmindia.com |
Employees and EPFO Compliance at Polypharm Private Limited
Polypharm Private Limited has a workforce of 11 employees as of Apr 01, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Polypharm Private Limited
Polypharm Private Limited has 6 board changes on record since 1997: 3 appointments and 3 cessations. The latest: Sheetal Pankaj Gupta ceased to be Additional Director on 30 Nov 2021.
6 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Polypharm Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Polypharm Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Polypharm Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Polypharm Private Limited
Polypharm has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACP2638N1Z4 | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Polypharm Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Polypharm Private Limited
Polypharm is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 July 1961 (65+ years old) and is registered under CIN U24239MH1961PTC012054.
Polypharm reported revenue of ₹8.92 Cr for FY 2025 (up 5% YoY).
Polypharm has 3 current directors:
- Sudha Prem Gupta - Director
- Sheetal Pankaj Gupta - Director
- Pankaj Prem Gupta - Director
Polypharm reported a net profit of ₹72.85 Lakh (net margin 8.2%) and EBITDA of ₹1.07 Cr (EBITDA margin 11.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Polypharm is 10% over three years and 11% over five years. In the latest year (FY 2025) revenue rose 5%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Polypharm is 27AAACP2638N1Z4, registered in Maharashtra.
The CIN (Corporate Identification Number) of Polypharm is U24239MH1961PTC012054. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Polypharm has 3 court cases on record: 2 filed by the company and 1 filed against it.
Polypharm was incorporated on 01 July 1961, making it 65+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Polypharm by revenue are Kudos Laboratories India Limited, Aies Pharma Chem Private Limited, Ish Medicos Private Limited, Genix Lifescience Private Limited, Grapple Lifesciences Private Limited and 5 more, all in the Pharma industry (Formulations).
Sheetal Pankaj Gupta ceased to be Additional Director on 30 Nov 2021. Sheetal Pankaj Gupta was appointed as Director on 14 Oct 2021. Puneet Prem Gupta ceased to be Director on 10 Feb 2020. Polypharm has 6 board changes on record in total.